Marta Otero Viñas
Director of The Tissue Repair and Regeneration Laboratory
Email: marta.otero@uvic.cat
ORCID: 0000-0003-2718-9977
Scientific Profile: URECERCA
Marta Otero is a professor in the Department of Biosciences and also serves as the Director of the Doctoral School at the University of Vic-Central University Catalonia (UVic-UCC). She began her research career working in Professor Lina Badimon’s laboratory, where she earned her Ph.D. working on cardiovascular disease research. Later, she focused her research on cutaneous wound healing and served as a visiting researcher in the Department of Dermatology at Boston University School of Medicine from 2014 to 2016.
Currently, Marta Otero leads the TR2Lab where she is dedicated to better understanding the mechanisms of tissue repair and regeneration. Her primary research interests are in the area of chronic wounds and she works on developing translational projects focused on cell-based therapeutics and tissue engineering.
Over the years, Marta Otero has held several leadership positions, including the Director of the Doctoral Program in Medicine and Biomedical Sciences (2019-2023), Vice-Dean for Research at the Faculty of Medicine at the UVic-UCC (2018-2019), and Director of Research and International Relations of the Faculty of Medicine at the UVic-UCC (2017-2018). She also served as the Vice President for research and knowledge transfer at the University of Vic-Central University of Catalonia (2008-2014). Previously, she created and developed the cell culture unit at the Cardiovascular Research Center in Barcelona from 2003 to 2006.
Marta Otero holds a Ph.D. in Biochemistry and Molecular Biology (2004) from Universitat de Barcelona, a Postgraduate degree in Strategic Management of Universities (2010) from Universitat Politècnica de Catalunya, and a Bachelor’s degree in Biochemistry (1999) and Chemistry (1999) from Universitat de Barcelona. Additionally, she received training in Human Subjects Research (2016) from the CITI Program and in working in Good Manufacturing Practices (GMP) facilities (2016) from Boston University School of Medicine.
My last happenings:
Phygital Bone: A biomimetic parametric model for 3D-printing human bone surrogates
Authors: Crespo-Santiago J*; Jordana X; Gesualdo M; Álvarez A; Andreu C; Mallafré H; Rzymelka V; Galtés I; Otero-Viñas M. Results in Engineering 2026 Jun;30:110448 DOI: 10.1016/j.rineng.2026.110448 Read More Abstract Accurate human bone surrogates are essential for biomechanical research. Existing commercial models provide limited control over microarchitectural features. In this study, we present Phygital Bone (PHyB), a biomimetic and fully customizable 3D-printed bone surrogate developed using algorithm-aided design (AAD) to reproduce key cortical and trabecular structures. PHyB specimens fabricated with commercially available resins were compared with fresh human femur samples and commercial surrogates. Structural validation was performed through [...]
TR2Lab was present at the EWMA 2026 Conference
TR2Lab was represented at the European Wound Management Association (EWMA) 2026 Conference by PhD candidate Clara Masó, who participated in this leading international event dedicated to advances in wound care, clinical practice, and translational research. This work was carried out with the collaboration of other members of TR2Lab, including Marta Casals-Zorita, Natàlia Palacio-Arronis, Marta Otero-Viñas and Marta Ferrer-Solà. During the congress, Clara Masó delivered an oral communication entitled “Impact of Punch Skin Grafting on the Quality of Life of Patients with Hard-to-Heal Wounds”. The presentation focused on the importance of evaluating patient-reported outcomes, particularly health-related quality of life (HRQoL), in individuals [...]
The diagnostic accuracy of HE4 in the differential diagnosis of pleural effusions.
Authors: Bérgamo S, Trapé J, González-García L, González-Fernández C, Vergara C, la-Torre ND, Bosch-Presegué L, Otero-Viñas M, Catot S, Crespo-Casal M, Rives-Jimenez J, Arnau A, Costa R, Cugat JR, Gonzalez-Sánchez F, Pla-Salas X, Sant F. Clin Chim Acta. 2025 Jan 30;566:120027. doi:10.1016/j.cca.2024.120027 Read More Abstract Background: Pleural effusions are challenging to diagnose, with approximately 20-50% of malignant effusions not diagnosed by cytology. Human epididymal protein 4 (HE4) may be useful in the differential diagnosis of pleural effusions. In serum, this biomarker shows false-positive results in some benign diseases. The aim of this study was to evaluate the diagnostic utility [...]
